Coexpression of glial and neuronal markers in the neurocytic rosettes of rosette-forming glioneuronal tumors

Brain Tumor Pathology

Volumn 31, Issue 1, 2014, Pages 17-22

  Matsumura, Nozomi ^a   Wang, Yin ^b   Nakazato, Yoichi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUDAN UNIVERSITY   (China)

Author keywords

Double immunostaining; Rosette forming glioneuronal tumor of the fourth ventricle; Triple immunostaining

Indexed keywords

CYCLIN D1; GLIAL FIBRILLARY ACIDIC PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SYNAPTOPHYSIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROCYTIC ROSETTE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ROSETTE FORMING CELL; ROSETTE FORMING GLIONEURONAL TUMOR OF THE FOURTH VENTRICLE;

ADOLESCENT; ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CEREBRAL VENTRICLE NEOPLASMS; CYCLIN D1; FEMALE; FOURTH VENTRICLE; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; ROSETTE FORMATION; YOUNG ADULT;

EID: 84895861307     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-012-0133-x     Document Type: Article

References (28)

1. Komori T, Scheithauer BW, Hirose T (2002) A rosette-forming glioneuronal tumor of the 4th ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor? Am J Surg Pathol 26:582-591 (Pubitemid 34438718)
2. Hainfellner JA, Scheithauer BW, Giangaspero F, Rosenblum MK (2007) Rosette-forming glioneuronal tumour of the fourth ventricle. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) The rise of World Health Organization classification of tumour of the central nervous system, 4th edn. International Agency for Research on Cancer (IARC), Lyon, pp 115-116
3. Wang Y, Xiong J, Chu SG, Liu Y, Cheng HX, Wang YF, Zhao Y, Mao Y (2009) Rosette-forming glioneuronal tumor: report of an unusual case with intraventricular dissemination. Acta Neuropathol 118:813-819
4. Luan SH, Zhuang DX, Sun LL, Huang FP (2010) Rosette-forming glioneuronal tumor (RGNT) of the fourth ventricle: case report and review of literature. Clin Neurol Neurosurg 112:362-364
5. Xiong J, Liu Y, Chu SG, Chen H, Chen HX, Mao Y, Wang Y (2011) Rosette-forming glioneuronal tumor of the septum pellucidum with extension to the supratentorial ventricles: rare case with genetic analysis. Neuropathology 32:301-305
6. Matsumura N, Yokoo H, Mao Y, Yin W, Nakazato Y (2012) Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell? Neuropathology. doi:10.1111/j.1440- 1789.2012.01355.x
7. Matsumoto Y, Tsunekawa Y, Nomura T, Suto F, Matsumata M, Tsuchiya S, Osumi N (2011) Differential proliferation rhythm of neural progenitor and oligodendrocyte precursor cells in the young adult hippocampus. PLoS ONE 6:e27628
8. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P (1988) Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333:560-562
9. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD (1988) Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333:562-565
10. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M (1988) A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53:309-319
11. Ellison JA, de Vellis J (1994) Platelet-derived growth factor receptor is expressed by cells in the early oligodendrocyte lineage. J Neurosci Res 37:116-128 (Pubitemid 24036483)
12. Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB (1996) Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res 43:299-314 (Pubitemid 26054018)
13. Nait Oumesmar B, Vignais L, Baron-Van Evercooren A (1997) Developmental expression of platelet-derived growth factor alpha-receptor in neurons and glial cells of the mouse CNS. J Neurosci 17:125-139 (Pubitemid 27008856)
14. Scholz M, Hoischen A, Radlwimmer B, Weber RG, Harders A, Reifenberger G, Riemenschneider MJ (2009) Rosetted glioneuronal tumor of the spine with overtly anaplastic histological features. Acta Neuropathol 117:591-593
15. Ghosal N, Furtado SV, Hegde AS (2010) Rosette forming glioneuronal tumor pineal gland and tectum: an intraoperative diagnosis on smear preparation. Diagn Cytopathol 38:590-593
16. Arai A, Sasayama T, Tamaki M, Sakagami Y, Enoki E, Ohbayashi C, Kohmura E (2010) Rosette-forming glioneuronal tumor of the fourth ventricle. Neurol Med Chir (Tokyo) 50:224-228
17. Solis OE, Mehta RI, Lai A, Mehta RI, Farchoukh LO, Green RM, Cheng JC, Natarajan S, Vinters HV, Cloughesy T, Yong WH (2011) Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases. J Neurooncol 102:477-484
18. Shan MN, Leonard JR, Perry A (2010) Rosette-forming glioneuronal tumors of the posterior fossa: report of 6 cases. J Neyrosurg Pediatr 5:98-103
19. Edgar MA, Rosenblum MK (2007) Mixed glioneuronal tumors: recently described entities. Arch Pathol Lab Med 131:228-233
20. Chakraborti S, Mahadevan A, Govindan A, Bhateja A, Dwarakanath S, Aravinda HR, Phalguni AA, Santosh V, Yasha TC, Rout P, Sampath S, Shankar SK (2012) Rosette-forming glioneuronal tumor-evidence of stem cell origin with biphenotypic differentiation. Virchows Arch. doi:10.1007/s00428-012-1313-0
21. Zhu JJ, Xiong J, Wang Y, Cheng HX, Mao Y, Gao MS, Li C (2009) Rosette-forming glioneuronal tumor of fourth ventricle: report of two cases. Zhonghua Bing Li Xue Za Zhi 38:850-851
22. Nakazato Y, Ishizeki J, Takahashi K, Yamaguchi H, Kamei T, Mori T (1982) Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomorphic adenoma of the salivary glands. Lab Invest 46:621-626 (Pubitemid 12081999)
23. Takebayashi H, Nabeshima Y, Yoshida S, Chisaka O, Ikenaka K, Nabeshima Y (2002) The basic helix-loop-helix factor Olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol 12:1157-1163 (Pubitemid 34766941)
24. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH (2002) Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109:75-86 (Pubitemid 34327518)
25. Sauvageot CM, Stiles CD (2002) Molecular mechanisms controlling cortical gliogenesis. Curr Opin Neurobiol 12:244-249 (Pubitemid 34615748)
26. Gelabert-Gonzalez M, Serramito-García R, Arcos-Algaba A (2011) Desmoplastic infantile and non-infantile ganglioglioma. Review of the literature. Neurosurg Rev 34:151-158 (Review)
27. Yamashita S, Yokogami K, Niibo T, Takeishi G, Ikeda T, Miyata S, Uehara H, Fukushima T, Nakazato Y, Takeshima H (2011) Oligodendroglial ganglioglioma. Brain Tumor Pathol 28:311-316
28. Yokoo H, Nobusawa S, Takebayashi H, Ikenaka K, Isoda K, Kamiya M, Sasaki A, Hirato J, Nakazato Y (2004) Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am J Pathol 164:1717-1725 (Pubitemid 38529774)